Articles By Eric Larson
-
Lifecore Biomedical Signs New Agreement With Indomo To Support Innovative Drug/Device Combination Acne Treatment
3/4/2026
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), and Indomo, a clinical-stage company dedicated to expanding access to quality healthcare via innovative device-enabled therapeutics, today announced that the companies have entered into a new development services agreement through which Lifecore will provide Indomo with a range of CDMO services to support the continued development of its corticosteroid drug candidate, DT-001.
-
03.03.26 -- Modernizing MES: Why Data Architecture Must Lead The Transformation
3/3/2026
03/03/26 Med Device Online Newsletter
-
The Sensitivity Trap: Building Confidence In CCIT Performance
3/2/2026
Effective CCIT goes beyond micron claims, focusing instead on repeatability, confidence, and real‑world relevance. Learn how to define a defensible LOD and understand what auditors truly prioritize.
-
03.01.26 -- Mastering Cultural Intelligence In Global Quality And Regulatory Leadership
3/1/2026
03/01/26 Med Device Online Newsletter
-
02.26.26 -- The Future Of Smart Manufacturing
2/26/2026
02/26/26
-
Choosing The Right Materials For Mico-Molded Optics And Photonics Components
2/26/2026
Choosing materials for optical micro molding requires balancing transmission, stability, and manufacturability—because in photonics, polymer selection directly determines real-world performance and reliability.
-
02.25.26 -- High‑Q, Non‑Magnetic Components for Precision Medical Imaging & Implantable Devices
2/25/2026
02/25/26 Med Device Online Newsletter
-
The Standard For Practical, Repeatable, And Globally Harmonized CCI
2/25/2026
Examine a dual‑mode approach that delivers precise, repeatable detection for both micro‑defects and larger breaches. Strengthen packaging quality and reduce investigation cycles with this platform.
-
What's Ahead For Medical Device Manufacturers
2/24/2026
Medical device manufacturers face growing complexity in 2026, needing stronger partnerships, advanced biomaterials, and resilient supply strategies to meet shifting patient, regulatory, and global market demands.
-
The Strategic Power Of Medical Device Coatings
2/24/2026
Medical device coatings are shifting from basic finishes to strategic tools that boost performance, safety, sustainability, and innovation through stronger partnerships, smarter materials, and collaborative development.